Breaking News Instant updates and real-time market news.

CROMF

Crombie REIT

$13.84 /

+ (+0.00%)

05:09
05/20/21
05/20
05:09
05/20/21
05:09

Crombie REIT resumed with an Outperform at National Bank

National Bank analyst Tal Woolley resumed coverage of Crombie REIT with an Outperform rating and C$18.50 price target. The analyst sees "very modest" dilution from the recent equity raise.

CROMF Crombie REIT
$13.84 /

+ (+0.00%)

05/11/21 Desjardins
Crombie REIT price target raised to C$17.50 from C$16 at Desjardins
05/10/21 National Bank
Crombie REIT price target raised to C$18.50 from C$17 at National Bank
05/10/21 TD Securities
Crombie REIT price target raised to C$16.50 from C$15.50 at TD Securities
04/27/21 Scotiabank
Crombie REIT upgraded to Outperform from Sector Perform at Scotiabank

TODAY'S FREE FLY STORIES

Hot Stocks
Cathie Wood's ARK Investment bought about 68K shares of Peloton on Friday  06:33
09/27/21
09/27
06:33
09/27/21
06:33
PTON

Peloton

$92.67 /

-1.66 (-1.76%)

 
ShowHide Related Items >><<
PTON Peloton
$92.67 /

-1.66 (-1.76%)

PTON Peloton
$92.67 /

-1.66 (-1.76%)

09/13/21 Goldman Sachs
Peloton initiated with a Neutral at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
09/10/21 DA Davidson
Affirm price target raised to $110 from $85 at DA Davidson
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
PTON Peloton
$92.67 /

-1.66 (-1.76%)

PTON Peloton
$92.67 /

-1.66 (-1.76%)

PTON Peloton
$92.67 /

-1.66 (-1.76%)

PTON Peloton
$92.67 /

-1.66 (-1.76%)

Hot Stocks
Cathie Wood's ARK Investment bought about 805K shares of Invitae on Friday  06:33
09/27/21
09/27
06:33
09/27/21
06:33
NVTA

Invitae

$30.06 /

-2.125 (-6.60%)

 
ShowHide Related Items >><<
NVTA Invitae
$30.06 /

-2.125 (-6.60%)

NVTA Invitae
$30.06 /

-2.125 (-6.60%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
NVTA Invitae
$30.06 /

-2.125 (-6.60%)

  • 22
    Jan
NVTA Invitae
$30.06 /

-2.125 (-6.60%)

NVTA Invitae
$30.06 /

-2.125 (-6.60%)

NVTA Invitae
$30.06 /

-2.125 (-6.60%)

Hot Stocks
Synlogic appoints Molly Harper as chief business officer » 06:32
09/27/21
09/27
06:32
09/27/21
06:32
SYBX

Synlogic

$3.18 /

+0.03 (+0.95%)

, RLMD

Relmada Therapeutics

$28.99 /

-0.44 (-1.50%)

Synlogic (SYBX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYBX Synlogic
$3.18 /

+0.03 (+0.95%)

RLMD Relmada Therapeutics
$28.99 /

-0.44 (-1.50%)

SYBX Synlogic
$3.18 /

+0.03 (+0.95%)

09/20/21 Chardan
Synlogic phenylketonuria data 'encouraging,' says Chardan
09/20/21 Piper Sandler
Synlogic price target raised to $9 at Piper Sandler on positive SynPHEny data
07/09/21 Chardan
Synlogic assumed with a Buy at Chardan
06/28/21 H.C. Wainwright
Synlogic price target lowered to $9 from $13 at H.C. Wainwright
RLMD Relmada Therapeutics
$28.99 /

-0.44 (-1.50%)

07/28/21 Truist
Relmada Therapeutics price target raised to $90 from $75 at Truist
07/27/21 Goldman Sachs
Relmada Therapeutics' positive data removes overhang, says Goldman Sachs
07/27/21 SVB Leerink
Relmada Therapeutics shares could move into $35-$40 range, says SVB Leerink
07/27/21 Truist
Relmada Therapeutics price target raised to $90 from $75 at Truist
SYBX Synlogic
$3.18 /

+0.03 (+0.95%)

RLMD Relmada Therapeutics
$28.99 /

-0.44 (-1.50%)

  • 23
    Sep
  • 16
    Apr
SYBX Synlogic
$3.18 /

+0.03 (+0.95%)

RLMD Relmada Therapeutics
$28.99 /

-0.44 (-1.50%)

Hot Stocks
Babcock & Wilcox unit awarded $35M contract » 06:31
09/27/21
09/27
06:31
09/27/21
06:31
BW

Babcock & Wilcox

$6.02 /

-0.29 (-4.60%)

Babcock & Wilcox…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BW Babcock & Wilcox
$6.02 /

-0.29 (-4.60%)

BW Babcock & Wilcox
$6.02 /

-0.29 (-4.60%)

03/25/21
Fly Intel: Top five analyst initiations
03/25/21 Lake Street
Babcock & Wilcox initiated with a Buy at Lake Street
03/25/21 DA Davidson
Babcock & Wilcox initiated with a Buy at DA Davidson
02/18/21
Fly Intel: Top five analyst initiations
BW Babcock & Wilcox
$6.02 /

-0.29 (-4.60%)

  • 10
    Feb
BW Babcock & Wilcox
$6.02 /

-0.29 (-4.60%)

Recommendations
Lordstown Motors price target lowered to $10 from $20 at BTIG » 06:31
09/27/21
09/27
06:31
09/27/21
06:31
RIDE

Lordstown Motors

$7.57 /

+0.125 (+1.68%)

BTIG analyst Gregory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIDE Lordstown Motors
$7.57 /

+0.125 (+1.68%)

RIDE Lordstown Motors
$7.57 /

+0.125 (+1.68%)

09/26/21 Goldman Sachs
Lordstown Motors downgraded to Sell from Neutral at Goldman Sachs
09/16/21 BofA
BofA cuts Lordstown Motors to Underperform, halves price target to $5
09/16/21 BofA
Lordstown Motors downgraded to Underperform from Neutral at BofA
08/12/21 RBC Capital
Lordstown Motors price target lowered to $1 from $5 at RBC Capital
RIDE Lordstown Motors
$7.57 /

+0.125 (+1.68%)

RIDE Lordstown Motors
$7.57 /

+0.125 (+1.68%)

RIDE Lordstown Motors
$7.57 /

+0.125 (+1.68%)

RIDE Lordstown Motors
$7.57 /

+0.125 (+1.68%)

Recommendations
Acceleron price target raised to $179 from $113 at RBC Capital » 06:27
09/27/21
09/27
06:27
09/27/21
06:27
XLRN

Acceleron

$167.52 /

+7.86 (+4.92%)

, BMY

Bristol-Myers

$60.23 /

-0.395 (-0.65%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

BMY Bristol-Myers
$60.23 /

-0.395 (-0.65%)

XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

08/05/21 Piper Sandler
Acceleron price target raised to $146 from $143 at Piper Sandler
07/19/21 Wolfe Research
Acceleron assumed with an Outperform at Wolfe Research
06/24/21 Oppenheimer
Acceleron price target raised to $160 from $141 at Oppenheimer
06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
BMY Bristol-Myers
$60.23 /

-0.395 (-0.65%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

BMY Bristol-Myers
$60.23 /

-0.395 (-0.65%)

XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

BMY Bristol-Myers
$60.23 /

-0.395 (-0.65%)

BMY Bristol-Myers
$60.23 /

-0.395 (-0.65%)

BMY Bristol-Myers
$60.23 /

-0.395 (-0.65%)

Recommendations
CarGurus price target raised to $59 from $46 at Benchmark » 06:26
09/27/21
09/27
06:26
09/27/21
06:26
CARG

CarGurus

$32.81 /

+0.83 (+2.60%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARG CarGurus
$32.81 /

+0.83 (+2.60%)

CARG CarGurus
$32.81 /

+0.83 (+2.60%)

08/26/21
Fly Intel: Top five analyst upgrades
08/26/21 RBC Capital
CarGurus upgraded to Outperform from Sector Perform at RBC Capital
08/12/21 Needham
CarGurus upgraded to Buy at Needham, sees stock close to bottom
08/12/21 Needham
CarGurus upgraded to Buy from Hold at Needham
CARG CarGurus
$32.81 /

+0.83 (+2.60%)

CARG CarGurus
$32.81 /

+0.83 (+2.60%)

Periodicals
GM to penalize employees who haven't reported vaccination status, WSJ reports » 06:25
09/27/21
09/27
06:25
09/27/21
06:25
GM

General Motors

$52.22 /

+0.31 (+0.60%)

General Motors has begun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$52.22 /

+0.31 (+0.60%)

GM General Motors
$52.22 /

+0.31 (+0.60%)

09/26/21 Goldman Sachs
General Motors price target lowered to $59 from $62 at Goldman Sachs
09/24/21 Citi
GM investor day could be 'significant positive catalyst,' says Citi
09/13/21 Barclays
General Motors price target lowered to $68 from $71 at Barclays
08/09/21 Jefferies
General Motors price target lowered to $53 from $68 at Jefferies
GM General Motors
$52.22 /

+0.31 (+0.60%)

GM General Motors
$52.22 /

+0.31 (+0.60%)

GM General Motors
$52.22 /

+0.31 (+0.60%)

GM General Motors
$52.22 /

+0.31 (+0.60%)

Periodicals
Acceleron in advanced talks to be acquired for about $180/share, Bloomberg says » 06:22
09/27/21
09/27
06:22
09/27/21
06:22
XLRN

Acceleron

$167.52 /

+7.86 (+4.92%)

Acceleron is in advanced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

08/05/21 Piper Sandler
Acceleron price target raised to $146 from $143 at Piper Sandler
07/19/21 Wolfe Research
Acceleron assumed with an Outperform at Wolfe Research
06/24/21 Oppenheimer
Acceleron price target raised to $160 from $141 at Oppenheimer
06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

XLRN Acceleron
$167.52 /

+7.86 (+4.92%)

General news
FX Action: USD-CAD printed a two-week low » 06:20
09/27/21
09/27
06:20
09/27/21
06:20
$ECON

Economic Data

/

+

FX Action: USD-CAD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
Citi reiterates $35 target on Plug Power after headquarter visit » 06:17
09/27/21
09/27
06:17
09/27/21
06:17
PLUG

Plug Power

$26.95 /

-0.83 (-2.99%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

09/23/21 Piper Sandler
Plug Power upgraded to Overweight from Neutral at Piper Sandler
09/17/21 JPMorgan
Plug Power on track to meet 2021, 2022 billings targets, says JPMorgan
08/31/21 Wolfe Research
Plug Power initiated with an Outperform at Wolfe Research
08/09/21 Truist
Plug Power price target lowered to $29 from $42 at Truist
PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

  • 27
    Jan
  • 17
    Nov
PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

Recommendations
Xylem analyst day to demonstrate its strong position, says RBC Capital » 06:16
09/27/21
09/27
06:16
09/27/21
06:16
XYL

Xylem

$135.58 /

+0.46 (+0.34%)

RBC Capital analyst Deane…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$135.58 /

+0.46 (+0.34%)

08/04/21 Credit Suisse
Xylem price target raised to $110 from $97 at Credit Suisse
08/04/21 RBC Capital
Xylem price target raised to $140 from $127 at RBC Capital
08/04/21 Citi
Xylem price target raised to $131 from $117 at Citi
06/18/21 Argus
Xylem initiated with a Buy at Argus
XYL Xylem
$135.58 /

+0.46 (+0.34%)

Upgrade
Camden Property upgraded to Buy from Neutral at BofA » 06:12
09/27/21
09/27
06:12
09/27/21
06:12
CPT

Camden Property

$149.76 /

-1.43 (-0.95%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPT Camden Property
$149.76 /

-1.43 (-0.95%)

09/23/21
Fly Intel: Top five analyst initiations
09/23/21 Deutsche Bank
Camden Property price target raised to $160 from $132 at Deutsche Bank
09/23/21 Goldman Sachs
Camden Property initiated with a Buy at Goldman Sachs
09/01/21 Barclays
Camden Property initiated with an Overweight at Barclays
CPT Camden Property
$149.76 /

-1.43 (-0.95%)

Hot Stocks
Genetron, IMPACT Therapeutics announce partnership » 06:11
09/27/21
09/27
06:11
09/27/21
06:11
GTH

Genetron

$13.90 /

-0.29 (-2.04%)

Genetron announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTH Genetron
$13.90 /

-0.29 (-2.04%)

GTH Genetron
$13.90 /

-0.29 (-2.04%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
GTH Genetron
$13.90 /

-0.29 (-2.04%)

Hot Stocks
Aslan Pharmaceuticals reports 'positive' results from Phase 1 study of ASLAN004 » 06:10
09/27/21
09/27
06:10
09/27/21
06:10
ASLN

Aslan Pharmaceuticals

$3.25 /

+0.01 (+0.31%)

ASLAN Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
03/17/21 H.C. Wainwright
Aslan Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
03/07/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $9 from $10 at Piper Sandler
ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

  • 03
    Mar
ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

Hot Stocks
AstraZeneca to present data on COVID and RSV during IDWeek Virtual Conference » 06:09
09/27/21
09/27
06:09
09/27/21
06:09
AZN

AstraZeneca

$60.36 /

+0.86 (+1.45%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

09/23/21 Gordon Haskett
Gordon Haskett compares Incyte to Alexion before Astra buyout
09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

Initiation
UnitedHealth initiated with an Outperform at SVB Leerink » 06:09
09/27/21
09/27
06:09
09/27/21
06:09
UNH

UnitedHealth

$407.15 /

-0.59 (-0.14%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

09/09/21 Cowen
UnitedHealth initiated with an Outperform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
09/01/21 KeyBanc
Quest Diagnostics price target raised to $168 from $144 at KeyBanc
UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

Periodicals
Deutsche Bank unit ignored calls to use ESG information, WSJ reports » 06:09
09/27/21
09/27
06:09
09/27/21
06:09
DB

Deutsche Bank

$12.69 /

+0.19 (+1.52%)

Fund managers at Deutsche…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

09/17/21 JPMorgan
Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan
08/13/21
Fly Intel: Top five analyst upgrades
08/13/21 Keefe Bruyette
Deutsche Bank upgraded to Market Perform from Underperform at Keefe Bruyette
07/29/21 Credit Suisse
Deutsche Bank price target raised to EUR 10.50 from EUR 10 at Credit Suisse
DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

Initiation
Privia Health initiated with an Outperform at SVB Leerink » 06:08
09/27/21
09/27
06:08
09/27/21
06:08
PRVA

Privia Health

$25.77 /

-0.98 (-3.66%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

09/09/21 Cowen
Privia Health initiated with a Market Perform at Cowen
08/10/21 Credit Suisse
Oak Street-driven dip provides opportunity in Cano, Privia, says Credit Suisse
08/09/21 Piper Sandler
Piper says Privia pullback due to market 'misinterpreting' new product news
07/14/21 Piper Sandler
Privia Health price target raised to $48 from $40 at Piper Sandler
PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

  • 29
    Apr
PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

Initiation
Acadia Healthcare initiated with an Outperform at SVB Leerink » 06:08
09/27/21
09/27
06:08
09/27/21
06:08
ACHC

Acadia Healthcare

$65.19 /

+0.05 (+0.08%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHC Acadia Healthcare
$65.19 /

+0.05 (+0.08%)

ACHC Acadia Healthcare
$65.19 /

+0.05 (+0.08%)

09/23/21 UBS
Acadia Healthcare initiated with Buy, $81 target at UBS
09/23/21 UBS
Acadia Healthcare initiated with a Buy at UBS
09/20/21 Credit Suisse
Credit Suisse upgrades 'compelling' Acadia Healthcare on recent selloff
09/20/21 Credit Suisse
Acadia Healthcare upgraded to Outperform from Neutral at Credit Suisse
ACHC Acadia Healthcare
$65.19 /

+0.05 (+0.08%)

Hot Stocks
PyroGenesis names Andre Mainella as CFO, succeeding Ben Simo » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
PYR

PyroGenesis

$3.99 /

-0.125 (-3.04%)

PyroGenesis Canada is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

Initiation
Humana initiated with an Outperform at SVB Leerink » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
HUM

Humana

$398.87 /

-3.07 (-0.76%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$398.87 /

-3.07 (-0.76%)

HUM Humana
$398.87 /

-3.07 (-0.76%)

09/24/21 Piper Sandler
1Life Healthcare price target lowered to $37 from $55.50 at Piper Sandler
09/09/21 Cowen
Humana initiated with an Outperform at Cowen
09/09/21 Barclays
Humana reinstated with an Overweight at Barclays
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
HUM Humana
$398.87 /

-3.07 (-0.76%)

HUM Humana
$398.87 /

-3.07 (-0.76%)

HUM Humana
$398.87 /

-3.07 (-0.76%)

Initiation
HCA Healthcare initiated with an Outperform at SVB Leerink » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
HCA

HCA Healthcare

$256.32 /

+0.79 (+0.31%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

09/23/21 UBS
HCA Healthcare initiated with Buy, $312 target at UBS
09/23/21 UBS
HCA Healthcare initiated with a Buy at UBS
09/09/21 Cowen
HCA's EBITDA outperformance remains underestimated, says Cowen
09/09/21 Cowen
HCA Healthcare initiated with an Outperform at Cowen
HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

Initiation
AdaptHealth initiated with an Outperform at SVB Leerink » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
AHCO

AdaptHealth

$23.01 /

-0.66 (-2.79%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
07/08/21 Jefferies
Medicare home oxygen proposal positive for AdaptHealth, says Jefferies
05/07/21 Canaccord
AdaptHealth price target lowered to $44 from $50 at Canaccord
AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

  • 06
    Jan
  • 15
    Dec
AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

Initiation
Agilon Health initiated with an Outperform at SVB Leerink » 06:05
09/27/21
09/27
06:05
09/27/21
06:05
AGL

Agilon Health

$28.11 /

-0.455 (-1.59%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

09/09/21 Cowen
Agilon Health initiated with an Outperform at Cowen
06/03/21 Wells Fargo
Agilon Health price target raised to $44 from $38 at Wells Fargo
05/28/21 Deutsche Bank
Agilon Health price target raised to $45 from $42 at Deutsche Bank
05/10/21 William Blair
William Blair sees Agilon Health as core holding, starts at Outperform
AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

  • 10
    Sep
  • 15
    Apr
AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.